Cargando…

Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis

BACKGROUND: The presence of asymptomatic spinal cord (SC) lesions in patients with clinically isolated syndrome (CIS) or relapsing-remitting multiple sclerosis (RRMS) predicts conversion to clinically definite multiple sclerosis (CDMS). The relation between asymptomatic SC abnormalities and disabili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dekker, Iris, Sombekke, Madeleine H, Witte, Birgit I, Geurts, Jeroen JG, Barkhof, Frederik, Uitdehaag, Bernard MJ, Killestein, Joep, Wattjes, Mike P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881784/ https://www.ncbi.nlm.nih.gov/pubmed/29106327 http://dx.doi.org/10.1177/1352458517736147

Ejemplares similares

Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability?
por: Dekker, Iris, et al.
Publicado: (2019)

The sequence of structural, functional and cognitive changes in multiple sclerosis
por: Dekker, Iris, et al.
Publicado: (2020)

Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients
por: Leurs, Cyra E, et al.
Publicado: (2017)

Increased functional sensorimotor network efficiency relates to disability in multiple sclerosis
por: Strik, Myrte, et al.
Publicado: (2020)

Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis
por: Huiskamp, Marijn, et al.
Publicado: (2021)

Predicting clinical progression in multiple sclerosis after 6 and 12 years
por: Dekker, I., et al.
Publicado: (2019)

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2021)

Gray matter networks and cognitive impairment in multiple sclerosis
por: Rimkus, Carolina M, et al.
Publicado: (2018)

Disease activity following pregnancy-related discontinuation of natalizumab in MS
por: Kleerekooper, Iris, et al.
Publicado: (2017)

Sensorimotor network dynamics predict decline in upper and lower limb function in people with multiple sclerosis
por: Strik, Myrte, et al.
Publicado: (2022)

Multiple sclerosis and drug discovery: A work of translation
por: ’t Hart, Bert A., et al.
Publicado: (2021)

The Use of Smartphone Keystroke Dynamics to Passively Monitor Upper Limb and Cognitive Function in Multiple Sclerosis: Longitudinal Analysis
por: Lam, Ka-Hoo, et al.
Publicado: (2022)

Three-Tesla MRI does not improve the diagnosis of multiple sclerosis: A multicenter study
por: Hagens, Marloes H.J., et al.
Publicado: (2018)

Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis
por: Loonstra, Floor C., et al.
Publicado: (2022)

Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis
por: Balk, Lisanne J, et al.
Publicado: (2017)

Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis
por: Lam, KH, et al.
Publicado: (2020)

The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing
por: van Kempen, Zoé LE, et al.
Publicado: (2017)

Smartphone‐derived keystroke dynamics are sensitive to relevant changes in multiple sclerosis
por: Lam, Ka‐Hoo, et al.
Publicado: (2021)

Concomitant granule cell neuronopathy in patients with natalizumab-associated PML
por: Wijburg, Martijn T., et al.
Publicado: (2016)

Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers
por: Coric, Danko, et al.
Publicado: (2017)

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light
por: Wessels, Mark HJ, et al.
Publicado: (2023)

Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla
por: Simon, Birgit, et al.
Publicado: (2010)

A more unstable resting-state functional network in cognitively declining multiple sclerosis
por: Broeders, Tommy A. A., et al.
Publicado: (2022)

Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2022)

Diagnostic relevance of high field MRI in clinical neuroradiology: the advantages and challenges of driving a sports car
por: Wattjes, Mike P., et al.
Publicado: (2012)

Natalizumab concentrations during pregnancy in three patients with multiple sclerosis
por: Toorop, Alyssa A, et al.
Publicado: (2021)

The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis
por: Coerver, Eline M. E., et al.
Publicado: (2022)

Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanner effects
por: Weeda, M.M., et al.
Publicado: (2019)

gMS-Classifier1 does not predict disability progression in multiple sclerosis
por: van Rossum, Johannis A, et al.
Publicado: (2018)

Cerebral rituximab uptake in multiple sclerosis: A (89)Zr-immunoPET pilot study
por: Hagens, Marloes HJ, et al.
Publicado: (2017)

Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment
por: Leurs, Cyra E, et al.
Publicado: (2017)

Cognitive functioning in everyday life: The development of a questionnaire on instrumental activities of daily living in multiple sclerosis
por: van Dam, Maureen, et al.
Publicado: (2021)

Lesion detection at seven Tesla in multiple sclerosis using magnetisation prepared 3D-FLAIR and 3D-DIR
por: de Graaf, Wolter L., et al.
Publicado: (2011)

The Holy Grail in diagnostic neuroradiology: 3T or 3D?
por: Barkhof, Frederik, et al.
Publicado: (2010)

Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study
por: Hagens, Marloes HJ, et al.
Publicado: (2018)

Feasibility of cognitive rehabilitation in patients with advanced multiple sclerosis: A pilot study
por: Prouskas, Stefanos E, et al.
Publicado: (2021)

Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab
por: Toorop, Alyssa A., et al.
Publicado: (2020)

Manual and automated tissue segmentation confirm the impact of thalamus atrophy on cognition in multiple sclerosis: A multicenter study
por: Burggraaff, Jessica, et al.
Publicado: (2020)

Infusion-related events during natalizumab: No need for post-infusion monitoring
por: Loonstra, Floor C, et al.
Publicado: (2019)

Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis
por: Uitdehaag, Bernard M. J.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qm3tiodgd4tou38jjld4lvdkou